Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice - Wikidata - awgldk - TriplyDB

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

http://www.wikidata.org/entity/Q35042502

about

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy Nanodiagnostics for tuberculosis detection.Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice.Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis An update on the use of rifapentine for tuberculosis therapy.Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.Update in tuberculosis and nontuberculous mycobacterial disease 2011.Nonclinical models for antituberculosis drug development: a landscape analysis.New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response.Emergence of airway smooth muscle mechanical behavior through dynamic reorganization of contractile units and force transmission pathways.Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.

P2860

Q27700967-B5851702-11FE-4054-B0EE-E74947BFBF85 Q28478840-A3D2112A-5BEB-4436-BDC4-8DA81434EA84 Q30235210-2C0B4F61-5A65-4E79-8F33-AEB204328931 Q30411475-91CFA847-BC65-4D11-A5F4-03F433C1820F Q33798173-7BBE782E-9F17-49BE-B7B7-0FF48D144C05 Q34708437-C3257ECC-B08A-430E-BE9A-3FBC22F4D249 Q35031351-B39A5BA8-DD5E-4872-96BF-EF1D235FD0A0 Q35084363-2AC51FC1-93F8-4A10-BB6B-1DD05D9ACFCB Q35169086-C6E94F72-311E-49B5-8317-2705302B54CB Q35607718-E7B1959C-9C79-4405-908F-95A56532FF5A Q35878689-562B49A5-5FA4-48E4-83E9-434214E79508 Q36018624-A353FF55-44A1-4156-905E-6D9357A81DF2 Q36086369-75AE5C99-4F4B-4A27-B1C7-DE883072C5D7 Q36171524-ED4B60A2-0BCC-4FD6-A745-82A7A3A928FB Q36236341-27A1B9E0-7C76-4571-8EF9-01B57B64D06E Q36364079-25235605-4DBD-4333-97A1-16C74869CC63 Q37334396-41B6FF12-ABCB-4A74-AAE3-D77574339EDA Q38019488-44028DCD-B40F-4A8D-8368-2F08B06A246D Q38502294-B8FC921C-6135-4DAA-9273-94CAF8E56125 Q38754367-38CCA08B-A07D-4D12-9735-C7360746F7A6 Q39987675-EAA5AE0C-8602-46B7-BD06-1048691A2260 Q40065997-F56DFF50-1B7E-45A7-8C92-3EB10FB8C420 Q46650295-CD0385C7-DD7F-45D4-B4CA-4743C90E1273 Q52606539-D2D93636-DAC1-4FB0-9837-92BEE98E10D0

P2860

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

http://www.wikidata.org/entity/Q35042502

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

@en

type

label

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

@en

prefLabel

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

@en

P1433

Q35042502-FB137AA2-E633-440C-A7BF-6CF3596BD530

P1476

Q35042502-1EE2E75F-0F0C-49E8-AD88-C3DEEC15F812

P2093

Q35042502-1D40A485-8903-4B23-A21D-F6B2A1E4D6EF

Q35042502-264BC768-8F53-4C39-BB74-EC8711F19152

Q35042502-2B04D13A-83D6-4865-8FD6-6248F5E02A1A

Q35042502-53F0517F-C3F3-4FE6-BBA1-1868AD7DFFA7

Q35042502-5C811637-F031-4B95-A790-4705090EABFD

Q35042502-649F76A9-6B1A-4DB3-A39F-6661679FD3CC

Q35042502-65B7D2E4-17B8-4DF3-A6B0-943E463F3109

Q35042502-B4EFA707-1465-45D7-A62C-639E9909D1F1

Q35042502-BDE2D553-E822-47BB-A5F6-D47076BA4BD7

P2860

Q35042502-0250E4F2-06DE-4EA1-909E-AC4F7E5A7D45

Q35042502-166059A4-D462-47B1-866F-39879F7189A0

Q35042502-197F4BF2-1D86-4E67-B536-3F60331B64AC

Q35042502-19B9525D-E0AD-42DB-9512-32811B5FB110

Q35042502-1FEC2A4D-8C82-48DB-96D9-CBE8DB062B72

Q35042502-20983348-B33B-4240-A068-D4974F96763D

Q35042502-22851282-5400-4492-B284-16FB9D05C382

Q35042502-24FD55DE-1419-448D-9A06-C4EB275B402B

Q35042502-3206FE8D-8D95-41C9-900F-401BA0432C8B

Q35042502-34BDA1E0-74FF-49CE-B101-FE03A2293184

P304

Q35042502-8D55DD1F-0399-4F9A-9DA6-EB92826774F5

P31

Q35042502-51139977-6462-44D4-AB74-69ABF985C956

P356

Q35042502-34DCD1B9-3F53-455A-B0B6-445EEE28366F

P407

Q35042502-0C33DD7B-BE31-46F2-ACE4-E7938FA000B9

P433

Q35042502-458EF926-5F97-4A58-852D-9C408BAC5430

P478

Q35042502-01CE0F95-D468-4CC8-8E23-A5013F9BC839

P577

Q35042502-A666ED35-C56D-4A83-AF74-99FDCA88EA11

P698

Q35042502-904CCE79-1B10-4D57-A621-FAB5177FD79F

P921

Q35042502-8C2BE727-B42E-4637-98B7-A02EC4BCDB2B

P932

Q35042502-9FF2A187-E773-4D1A-A33C-21B00038B91C

P356

RCCM.201012-1949OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

@en

P2093

Charles A Peloquin

http://www.w3.org/2001/XMLSchema#string

Deepak V Almeida

http://www.w3.org/2001/XMLSchema#string

Eric L Nuermberger

http://www.w3.org/2001/XMLSchema#string

Ian M Rosenthal

http://www.w3.org/2001/XMLSchema#string

Jacques H Grosset

http://www.w3.org/2001/XMLSchema#string

Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Paul J Converse

http://www.w3.org/2001/XMLSchema#string

Si-Yang Li

http://www.w3.org/2001/XMLSchema#string

Zahoor Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.

Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.

Treatment outcomes of patients with HIV and tuberculosis.

P304

1254-1261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201012-1949OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21330452

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3114054

http://www.w3.org/2001/XMLSchema#string